Argent BioPharma plans to delist from LSE by December 31, 2024.
Posted on: 28/11/2024
Argent BioPharma reports collaboration with SINTEF and voluntary delisting from ASX.
Posted on: 31/10/2024
Argent BioPharma lists on OTCQB and appoints new CFO.
Posted on: 29/07/2024